VADSP Pharmaceuticals: drug alert entries
Batches made by VADSP Pharmaceuticals (as named by CDSCO) that appear in CDSCO drug alerts: 14 entries. For spurious entries, the named company may be the brand owner rather than the actual maker.
Aceclofenac & Paracetamol Tablets (Peonac-P)NSQ
Result: content- Paracetamol
Cefpodoxime & Potassium Clavulanate tablets (LIOPOD-CV Tablets)NSQ
Result: Sample Does not complies for the Assay of Cefpodoxime and Clavulanic Acid, hence it is Not of Standard Quality.
Ceftriaxone & Sulbactam for Injection IP (Action Vet CS)NSQ
Result: The sample does not conforms to I.P., in respect of clarity of solution, particulate matter and Assay of both Ceftriaxone & Sulbactam,
Ceftriaxone & Tazobactam InjectionNSQ
Result: The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Acts and rules with respect to test for Sterility (Powder for Injection) and Assay/content of Tazobactam and Ceftriaxone.
Amoxycillin & Potassium Clavulanate Tablets IP (Javiclav 625)NSQ
Result: The sample does not conform to I.P. w.r.to the tests for Dissolution and Assay of Clavulanic Acid
Cefixime Dispersible Tablet IP (FIMI 100)NSQ
Result: The sample does not conform to the IP with respect to Assay of Cefixime Trihydrate eq. to Anhydrous Cefixime.
Amoxycillin & Potassium Clavulanate Tablets IP (Miximox CV 625 Tab)NSQ
Result: Dissolution test and content of Clavulanic Acid
Amoxycillin & Potassium Clavulanate Tablets IP (Clam-625 Tablets)NSQ
Result: The Sample does not meets the Specifications wrt. Assay and Dissolution of Clavulanic acid as per IP.
Thiamine Riboflavin, Niacinamide, Cynocobalamin & Liver Crude Injection (LIVGROW) Vetrinary Injection.NSQ
Result: The sample does not conform to the claim with respect to Assay of Cynocobalamin (Nil) and Riboflavin (Nil)
Aceclofenac and Thiocolchicoside Tablets (GB MEF-300)NSQ
Result: The sample does not conform to IP 2022 requirements w.r.t Assay of Thiocolchicoside
Cefpodoxime Proxetil Tablets IP (QCE POD 200 MG)NSQ
Result: The sample does not conform to the I.P. with respect to Assay of Cefpodoxime Proxetil eq. to Cefpodoxime.
Cefpodoxine Proxetil Tablets IP (QCE POD 200 MG)NSQ
Result: The sample does not conform to the IP as it does not contain Cefpodoxime (Nil)
Cefuroxime Axetil Tablets IP (EXTENSIVE-500)NSQ
Result: The sample does not conform to the IP with respect to Assay.
Amoxycillin Potassium Clavulanate & Lactic Acid Bacillus Tablets (Killmed 625LB)NSQ
Result: The sample does not conform to the claim as it does not contain Clavulanic Acid (Nil).